Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Hassett DJ, Borchers MT, Panos RJ.

J Microbiol. 2014 Mar;52(3):211-26. doi: 10.1007/s12275-014-4068-2. Review.

PMID:
24585052
2.
3.

Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection.

Gally F, Chu HW, Bowler RP.

PLoS One. 2013;8(1):e51784. doi: 10.1371/journal.pone.0051784.

4.

Pseudomonas aeruginosa biofilms in cystic fibrosis.

Høiby N, Ciofu O, Bjarnsholt T.

Future Microbiol. 2010 Nov;5(11):1663-74. doi: 10.2217/fmb.10.125. Review.

PMID:
21133688
5.

Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients.

Engler K, Mühlemann K, Garzoni C, Pfahler H, Geiser T, von Garnier C.

Swiss Med Wkly. 2012 Jan 30;142:w13509. doi: 10.4414/smw.2012.13509.

6.

Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.

Tolker-Nielsen T.

APMIS Suppl. 2014 Dec;(138):1-51. doi: 10.1111/apm.12335. Review.

PMID:
25399808
7.

Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.

Dales L, Ferris W, Vandemheen K, Aaron SD.

Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1275-9. doi: 10.1007/s10096-009-0774-9.

PMID:
19575248
8.

[Chronic bronchial infection: the problem of Pseudomonas aeruginosa].

Cantón R, Fernández Olmos A, de la Pedrosa EG, del Campo R, Antonia Meseguer M.

Arch Bronconeumol. 2011 Jun;47 Suppl 6:8-13. doi: 10.1016/S0300-2896(11)70029-1. Spanish.

9.

Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.

Watters C, Everett JA, Haley C, Clinton A, Rumbaugh KP.

Infect Immun. 2014 Jan;82(1):92-100. doi: 10.1128/IAI.00651-13.

10.

The clinical impact of bacterial biofilms.

Høiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PØ, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T.

Int J Oral Sci. 2011 Apr;3(2):55-65. doi: 10.4248/IJOS11026. Review.

11.

Lower respiratory tract infections in chronic obstructive pulmonary disease outpatients with tracheostomy and persistent colonization by P. aeruginosa.

Lusuardi M, Capelli A, Di Stefano A, Zaccaria S, Balbi B, Donner CF.

Respir Med. 2003 Nov;97(11):1205-10.

PMID:
14635975
12.

The role of bacterial biofilms in chronic infections.

Bjarnsholt T.

APMIS Suppl. 2013 May;(136):1-51. doi: 10.1111/apm.12099.

PMID:
23635385
13.

Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.

Bjarnsholt T, Tolker-Nielsen T, Høiby N, Givskov M.

Expert Rev Mol Med. 2010 Apr 7;12:e11. doi: 10.1017/S1462399410001420. Review.

PMID:
20370936
14.

Dendritic cells in pathogenesis of COPD.

Givi ME, Redegeld FA, Folkerts G, Mortaz E.

Curr Pharm Des. 2012;18(16):2329-35. Review.

PMID:
22390696
15.

Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.

Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO.

Trends Microbiol. 2009 Mar;17(3):130-8. doi: 10.1016/j.tim.2008.12.003. Review.

PMID:
19231190
16.

Chronic obstructive pulmonary disease in women: exploring gender differences.

Varkey AB.

Curr Opin Pulm Med. 2004 Mar;10(2):98-103. Review.

PMID:
15021178
17.

Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Gellatly SL, Hancock RE.

Pathog Dis. 2013 Apr;67(3):159-73. doi: 10.1111/2049-632X.12033. Review.

18.

Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.

Jakobsen TH, Bjarnsholt T, Jensen PØ, Givskov M, Høiby N.

Future Microbiol. 2013 Jul;8(7):901-21. doi: 10.2217/fmb.13.57. Review.

PMID:
23841636
19.

Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers.

Comer DM, Kidney JC, Ennis M, Elborn JS.

Eur Respir J. 2013 May;41(5):1058-67. doi: 10.1183/09031936.00063112.

20.

Mechanisms of bacterial resistance to antibiotics in infections of COPD patients.

Kyd JM, McGrath J, Krishnamurthy A.

Curr Drug Targets. 2011 Apr;12(4):521-30. Review.

PMID:
21194403
Items per page

Supplemental Content

Support Center